AAAAAA
Results: 26-29/29
Authors:
Grunblatt, E
Mandel, S
Royak, Y
Youdim, MBH
Citation: E. Grunblatt et al., Contribution of intracellular non-haem iron, NF-kappa B activation and inflammatory responses to neurodegeneration in Parkinson's Disease: Prospects for neuroprotection, NEUROTOXIC FACTORS IN PARKINSON'S DISEASE AND RELATED DISORDERS, 2000, pp. 277-288
Authors:
Mohanakumar, KP
Muralikrishnan, D
Citation: Kp. Mohanakumar et D. Muralikrishnan, Neurochemical mechanisms underlying neuroprotective actions of bromocriptine, salicylate, D- and L-deprenyl in neurodegeneration caused by MPTP, NEUROTOXIC FACTORS IN PARKINSON'S DISEASE AND RELATED DISORDERS, 2000, pp. 289-293
Authors:
Blessing, H
Bareiss, M
Jankowski, S
Ling, ZD
Carvey, P
Schwarz, J
Storch, A
Citation: H. Blessing et al., Attenuation of levodopa-induced toxicity in primary dopamine neurons by catechol-O-methyltransferase inhibition, NEUROTOXIC FACTORS IN PARKINSON'S DISEASE AND RELATED DISORDERS, 2000, pp. 295-300
Authors:
Lastres-Becker, I
Romero, J
Berrendero, F
Perez-Rosado, A
Manzanares, J
Rojo, A
Fernandez-Ruiz, J
de Yebenes, JG
Ramos, JA
Citation: I. Lastres-becker et al., Unilateral 6-hydroxydopamine lesions of nigrostriatal dopaminergic neuronsincreased cannabinoid CB1 receptor mRNA levels in the rat striatum: Possible therapeutic implications, NEUROTOXIC FACTORS IN PARKINSON'S DISEASE AND RELATED DISORDERS, 2000, pp. 301-305